Literature DB >> 9813559

Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent.

S M Maguire1, A G Nugent, C McGurk, G D Johnston, D P Nicholls.   

Abstract

OBJECTIVE: To study underlying vascular responses in chronic heart failure in patients without ACE inhibitor treatment, and to compare them with age matched controls.
DESIGN: Forearm blood flow was studied using venous occlusion plethysmography in patients with chronic heart failure (n = 12) and matched controls (n = 13), after infusion of L-NMMA (a nitric oxide synthase inhibitor), glyceryl trinitrate (an endothelium independent vasodilator), and serotonin (an endothelium dependent vasodilator).
RESULTS: L-NMMA produced significant vasoconstriction in normal subjects (forearm blood flow reduced by 24%), but not in patients (6%; difference between groups p < 0.03). The vasodilator responses to glyceryl trinitrate were impaired in patients (p < 0.02). In normal controls, serotonin produced initial dilatation, followed by vasoconstriction at high doses. In patients, no vasodilator responses were observed, only late vasoconstriction (p < 0.03).
CONCLUSIONS: The vascular responses of patients are confirmed as being abnormal. The lack of response to L-NMMA suggests that nitric oxide does not contribute to basal vascular tone in patients with chronic heart failure. The responses to glyceryl trinitrate and to serotonin suggest that there is both smooth muscle and endothelial dysfunction in patients with chronic heart failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813559      PMCID: PMC1728779          DOI: 10.1136/hrt.80.2.141

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  40 in total

1.  Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.

Authors:  S D Katz; M Schwarz; J Yuen; T H LeJemtel
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

2.  Increased nitric oxide production in heart failure.

Authors:  D S Winlaw; G A Smythe; A M Keogh; C G Schyvens; P M Spratt; P S Macdonald
Journal:  Lancet       Date:  1994-08-06       Impact factor: 79.321

Review 3.  Control of nitric oxide and prostacyclin synthesis in endothelial cells.

Authors:  R Busse; M Hecker; I Fleming
Journal:  Arzneimittelforschung       Date:  1994-03

4.  Depressed beta-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure.

Authors:  K Kiuchi; N Sato; R P Shannon; D E Vatner; K Morgan; S F Vatner
Journal:  Circ Res       Date:  1993-12       Impact factor: 17.367

5.  Role of nitric oxide in exercise-induced vasodilation of the forearm.

Authors:  T Endo; T Imaizumi; T Tagawa; M Shiramoto; S Ando; A Takeshita
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

6.  Lack of contribution of nitric oxide to basal vasomotor tone in heart failure.

Authors:  S H Kubo; T S Rector; A J Bank; L Raij; M D Kraemer; P Tadros; M Beardslee; M D Garr
Journal:  Am J Cardiol       Date:  1994-12-01       Impact factor: 2.778

7.  Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure.

Authors:  M Nakamura; T Funakoshi; N Arakawa; H Yoshida; S Makita; K Hiramori
Journal:  J Am Coll Cardiol       Date:  1994-11-01       Impact factor: 24.094

8.  Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?

Authors:  F Habib; D Dutka; D Crossman; C M Oakley; J G Cleland
Journal:  Lancet       Date:  1994-08-06       Impact factor: 79.321

9.  Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure.

Authors:  C J Smith; D Sun; C Hoegler; B S Roth; X Zhang; G Zhao; X B Xu; Y Kobari; K Pritchard; W C Sessa; T H Hintze
Journal:  Circ Res       Date:  1996-01       Impact factor: 17.367

10.  No functional involvement of 5-hydroxytryptamine1A receptors in nitric oxide-dependent dilatation caused by serotonin in the human forearm vascular bed.

Authors:  T A Bruning; P A van Zwieten; G J Blauw; P C Chang
Journal:  J Cardiovasc Pharmacol       Date:  1994-09       Impact factor: 3.105

View more
  6 in total

Review 1.  Endothelial function and nitric oxide: clinical relevance.

Authors:  P Vallance; N Chan
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

Review 2.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Jessica H Huston; Sanjiv J Shah
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

Review 3.  Nitric oxide in the pathogenesis of cardiac disease.

Authors:  Leopoldo Raij
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

Review 4.  Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.

Authors:  Matthias Oelze; Swenja Schuhmacher; Andreas Daiber
Journal:  Exp Diabetes Res       Date:  2010-12-27

5.  Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance.

Authors:  Anida Velagic; Jasmin Chendi Li; Cheng Xue Qin; Mandy Li; Minh Deo; Sarah A Marshall; Dovile Anderson; Owen L Woodman; John D Horowitz; Barbara K Kemp-Harper; Rebecca H Ritchie
Journal:  Br J Pharmacol       Date:  2022-04-26       Impact factor: 9.473

6.  Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction.

Authors:  Dirk J Duncker; Vincent J de Beer; Daphne Merkus
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.